Death risk among COVID-19 patients in Yazd, Iran: a hospital-based case-cohort study

Document Type : Original Research

Authors

1 Clinical Research Development Center of Shahid Sadoughi Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

2 Medical Genetics Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

3 Students Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran

4 Biostatistics and Epidemiology Department, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

Abstract

Background and Aim: The COVID-19 epidemic control has become a global challenge and many contributing variables are still unknown to policymakers. This case-cohort study was conducted to investigate the risk factors of mortality in COVID-19 patients.
Methods: This case-cohort study was conducted on 1465 samples in Yazd Province in the first six months of 2020. Data analysis was done using descriptive statistics and chi-square, and Cox regression analysis.
Results: Of a total cohort population of 1465, 1236 were assigned to the control group and 229 were assigned to the case group. The results of multiple Cox regression showed that increasing one year of age increases the chance of death by 2.7% (HR = 1.027, P < /em> <0.001). Having cardiovascular disease, diabetes, chronic neurological disease, chronic lung disease and malignancy increases the chance of death. Patients admitted to the intensive care unit had a 200% higher risk of death than others (HR = 3.009, P < /em> <0.001).
Conclusion: The results showed a higher mortality rate in elderly patients as well as those with underlying diseases. Attention should be paid to at-risk and elderly patients in terms of ensuring a healthy diet, improving their self-care practices, and providing long-term medical and healthcare facilities.

Keywords

References

1. Farnoosh G, Alishiri G, Hosseini Zijoud SR, Dorostkar R, Jalali Farahani A. Understanding the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease (COVID-19) Based on Available Evidence-A Narrative Review. J Mil Med. 2020;22(1):1-11. 2. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet. 2020;395(10224):565-74. 3. Tyrrell D, Bynoe M. Cultivation of a novel type of common-cold virus in organ cultures. British medical journal. 1965;1(5448):1467. 4. Chan JF-W, Yuan S, Kok K-H, To KK-W, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The Lancet. 2020;395(10223):514-23. 5. Gralinski LE, Menachery VD. Return of the Coronavirus: 2019-nCoV. Viruses. 2020;12(2):135. 6. Xu K, Lai X, Liu Z. Suggestions for prevention of 2019 novel coronavirus infection in otolaryngology head and neck surgery medical staff. Zhonghua er bi yan hou tou jing wai ke za zhi= Chinese journal of otorhinolaryngology head and neck surgery. 2020;55:E001. 7. Alimohamadi Y, Sepandi M. Basic Reproduction Number: An important Indicator for the Future of the COVID-19 Epidemic in Iran. Journal Mil Med. 2020;22(1):96-7. 8. Liu K, Chen Y, Lin R, Han K. Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients. Journal of Infection. 2020. 9. Covid C, Team R. Severe outcomes among patients with coronavirus disease 2019 (COVID-19)—United States, February 12–March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(12):343-6. 10. China C. Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. Vital surveillance: The epidemiological characteristics of an outbreak of. 2019. 11. Alshahrani MS, Sindi A, Alshamsi F, Al-Omari A, El Tahan M, Alahmadi B, et al. Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus. Annals of intensive care. 2018;8(1):3. 12. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. Jama. 2020;323(13):1239-42. 13. Zhang J, Wang X, Jia X, Li J, Hu K, Chen G, et al. Risk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, China. Clinical Microbiology and Infection. 2020. 14. Shi Q, Zhang X, Jiang F, Zhang X, Hu N, Bimu C, et al. Clinical characteristics and risk factors for mortality of COVID-19 patients with diabetes in Wuhan, China: a two-center, retrospective study. Diabetes Care. 2020. 15. Thai PQ, Dinh TS, Van Hoang TH, Luu NM, Hung LX, Luu NH, et al. Factors associated with the duration of hospitalization among COVID-19 patients in Vietnam: A survival analysis. Epidemiology & Infection. 2020:1-20. 16. Allcock SH, Young EH, Sandhu MS. Sociodemographic patterns of health insurance coverage in Namibia. International journal for equity in health. 2019;18(1):16. 17. Lescure F-X, Bouadma L, Nguyen D, Parisey M, Wicky P-H, Behillil S, et al. Clinical and virological data of the first cases of COVID-19 in Europe: a case series. The Lancet Infectious Diseases. 2020. 18. Wise J. A third of covid-19 patients admitted to UK hospitals die. British Medical Journal Publishing Group; 2020. 19. Taylor E, Hofmeyr R, Torborg A, van Tonder C, Boden R, Earle E, et al. Risk factors and interventions associated with mortality or survival in adult COVID-19 patients admitted to critical care: a systematic review and meta-analysis. Southern African Journal of Anaesthesia and Analgesia. 2020;26(3):116-27. 20. Ma J, Xia P, Zhou Y, Liu Z, Zhou X, Wang J, et al. Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19. Clinical Immunology (Orlando, Fla). 2020;214:108408. 21. Pan C, Chen L, Lu C, Zhang W, Xia J-A, Sklar MC, et al. Lung Recruitability in COVID-19–associated Acute Respiratory Distress Syndrome: A Single-Center Observational Study. American journal of respiratory and critical care medicine. 2020;201(10):1294-7. 22. Ren L-L, Wang Y-M, Wu Z-Q, Xiang Z-C, Guo L, Xu T, et al. Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chinese medical journal. 2020.
Journal of Military Medicine
Volume 23, Issue 3 - Serial Number 100
May and June 2021
Pages 274-282

Files

Share

How to cite

Statistics